News EMA advisors say CSL's Tavneos should be pulled from sale Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.
News Obesity is rising fastest in young adults in England An analysis of around 54m health records in England has revealed rising rates of obesity, particularly among young adults and disadvantaged groups.
News NICE delivers more good news for cervical cancer patients Hundreds of women with locally advanced cervical cancer are to be offered MSD's Keytruda on the NHS in England, thanks to new NICE guidance.
News Sanofi's type 1 diabetes-delaying drug cleared for NHS use People with early type 1 diabetes in England and Wales will soon be able to access Sanofi's Tzield, which can delay the need for insulin injections.
News AI agents can beat doctors in clinical decision-making Two AIs have shown they can match doctors across diagnostic and treatment tasks, but their developers say they aren't ready yet for real-world use.
News Dispensing data exposes health inequalities in England A study linking dispensing data to patient characteristics in England has exposed differences in medicine use across ethnic and socioeconomic groups.
News Roivant wins FDA approval for first targeted dermatomyositis... Roviant & Priovant Therapeutics finally secure US approval for once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for dermatomyositis.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.